Takeda Clinical Trials - BlackDoctor.org - Where Wellness & Culture Connect

Lattitude_PSA

A Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Stratified by Prior Biologic Use

Trial Name:
TAK-279-PsA-3002

Condition:
Psoriatic Arthritis

Testing For:
Placebo, Zasocitinib

Age:
18 years and older

Phase:
3

See If You Qualify
A Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying

Trial Name:
TAK-279-PsA-3001

Condition:
Psoriatic Arthritis

Testing For:
Placebo, Zasocitinib, Active Comparator

Age:
18 years and older

Phase:
3

See If You Qualify

Ask me something!